Tonight on CNBC’s Mad Money, Jim Cramer said he was ready to eat crow over Herbalife (HLF-NYSE) because it is a supplement company that he got wrong. It sells via Multi-level marketing and that uses 3rd party manufacturers. He thought it was bad, but now he says that this one deserves to trade higher rather than lower. The earnings were better and guidance in-line, plus they just got approval to market in 2 Chinese provinces. It has high margins and strong cash flow. They rejected a $38.00 bid from J.H.Whitney, so this should have a fairly clear floor. It also has a large buyback and a decent dividend. A new CEO cut down some of the distributors down.
This one traded up 2.4% to $40.34 in after-hours, after closing up 0.4% at $39.39 today. The 52-week trading range is $27.73 to $42.54.
Jon C. Ogg
May 15, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
